https://www.selleckchem.com/pr....oducts/Rosuvastatin-
positioning and management will lead to excellent outcomes. Increasing evidence shows that patients with Metabolic Syndrome (MetS) are at risk for adverse outcome after abdominal surgery. The aim of this study was to investigate the impact of MetS and preoperative hyperglycemia, as an individual component of MetS, on adverse outcome after colorectal surgery. A literature review was systematically performed according to the PRISMA guidelines. Inclusion criteria were observational studies that evaluated the relations
Like
Comment
Share
